Westmount Partners Q2 2026 Investment Activity

As reported in the latest filing, Westmount Partners, Llc's portfolio saw an increase in its total holdings count to 255 stocks during Q2 2026. The investor maintained a significant focus on the Technology sector, holding major positions like Apple Inc (AAPL), which increased by over 1% in weight and more than 6.8% in value.

Prominent Purchases

Westmount Partners demonstrated notable buying activity during the quarter, particularly favoring Technology and Healthcare sectors for new or significantly increased positions:

• Technology Focus: The investor acquired substantial quantities of several Technology ETFs. This included significant additions to Blend Labs Inc (BLND), increasing its position by 100% and adding just over $7,695 in value; similarly, they added a large amount to Invesco Exchange Traded Fund Trust II (IDMO), boosting its allocation by 100% and adding over $2.4 million in value.
• Healthcare Acquisitions: In the Healthcare sector, Westmount Partners significantly increased their position in Allogene Therapeutics Inc (ALLO), adding 100% of its current holding ($74,880 added). They also substantially boosted their stake in Illumina Inc (ILMN) by over 35%, increasing the share count by nearly 12,400 shares and adding more than $3.9 million to its value.
• Mutual Funds: The investor also purchased a considerable amount of MGK Fund, increasing the position by nearly 400% (adding over 7,121 shares) and contributing $782,926 to its value.
• ETF Diversification: Other ETF purchases included Vanguard Information Technology ETF (VUG), which saw a nearly 417% increase in shares, adding over $3.7 million; and additions to iShares Core US Tech ETF (IWF) (+303%) and iShares Semiconductor ETF (DGRO) (+100%).
• Tax-Managed Focus: The investor also added to the Vanguard Tax-Managed Small Cap Equity Fund (VEA) by nearly 48%, adding over $1.9 million.
• International Exposure: Finally, Westmount Partners increased their position in the Vanguard FTSE Developed International ETF (VGT) by almost 580%, adding nearly $1.2 million.

Substantial Sales and Sector Shifts

In contrast to the buying activity, Westmount Partners also divested significant portions of their portfolio during Q2:

• Major Healthcare Exit: The most substantial sale was in the Healthcare sector. They sold nearly 43% (a reduction by over 43%) of shares held in iShares Core Healthcare ETF, reducing its position significantly and contributing $750,922 to the portfolio's value decrease.
• Technology Value Reduction: While not selling major Technology stocks outright (like Apple or Microsoft), they reduced their allocation in several other Tech-related holdings. This included decreasing shares in IDMO, though this ETF was also a significant purchase, and reducing positions in VUG (despite buying it) and DGRO.
• Sector Realignment: Overall, the portfolio's allocation shifted away from Healthcare (-5.37% in value), reducing its prominence as a sector focus compared to Technology (+$14.1 million added). Other sectors like Consumer Cyclical also saw reductions.

Miscellaneous Changes and ETF Activity

Westmount Partners made adjustments across various other holdings:

• ETF Replacements: They sold their position in the Vanguard Intl Equity Index Fund (VT) entirely, reducing its allocation by 100% ($9.3 million removed), while simultaneously increasing shares in SPY (S&P 500 ETF) and other funds like VEA.
• Moderate Activity: Changes were also observed in smaller allocations, such as MSFT, AMZN, and GOOGL. Some adjustments were minor, while others represented moderate changes.
• Position Changes: The investor frequently adjusted their position sizes, indicating active management of the portfolio's risk and exposure profile throughout the quarter.

The overall pattern suggests a dynamic investment strategy focused on capitalizing on growth opportunities in Technology while strategically reducing exposure in certain Healthcare areas. Further details can be explored by visiting Westmount Partners, Llc's profile or analyzing individual stock changes.